MARKET

BMY

BMY

Bristol-Myers Squibb Co
NYSE
60.77
-1.22
-1.97%
Pre Market: 60.55 -0.22 -0.36% 06:03 02/10 EST
OPEN
61.37
PREV CLOSE
61.99
HIGH
61.63
LOW
60.36
VOLUME
51
TURNOVER
--
52 WEEK HIGH
62.05
52 WEEK LOW
41.88
MARKET CAP
123.71B
P/E (TTM)
17.57
1D
5D
1M
3M
1Y
5Y
1D
Bristol-Myers Squibb (BMY) Is Up 8.7% After Swing To Profit And AI-Focused R&D Push
Simply Wall St · 10h ago
Weekly Report: what happened at BMY last week (0202-0206)?
Weekly Report · 1d ago
Notable healthcare headlines for the week: Pfizer Novo Nordisk in focus
Seeking Alpha · 1d ago
A Look At Bristol Myers Squibb (BMY) Valuation After Earnings Beat And Strong 2026 Guidance
Simply Wall St · 2d ago
Big Pharma's Earnings Week: Strong Performance, Obesity Wars, LOE Management And More
Seeking Alpha · 2d ago
Bristol Myers Squibb (BMY) Returns To US$7.1b Trailing Profit Challenging Bearish Narratives
Simply Wall St · 3d ago
Bristol-Myers Squibb: A Dividend Gem With Hidden Upside In 2026
Seeking Alpha · 3d ago
Bristol-Myers Squibb Is Maintained at Neutral by Citigroup
Dow Jones · 3d ago
More
About BMY
Bristol-Myers Squibb Company is a global biopharmaceutical company. It is engaged in the discovery, development and delivery of transformational medicines for patients facing serious diseases in areas: oncology, hematology, immunology, cardiovascular, neuroscience and other areas. Its growth portfolio includes Opdivo (nivolumab), Opdivo Qvantig (nivolumab and hyaluronidase-nvhy), Yervoy (ipilimumab), Reblozyl (luspatercept-aamt), Opdualag (nivolumab and relatlimab-rmbw), Breyanzi (lisocabtagene maraleucel), Camzyos (mavacamten), Zeposia (ozanimod), Abecma (idecabtagene vicleucel), and Sotyktu (deucravacitinib). Its other growth products include Onureg, Inrebic, and Empliciti. Its legacy portfolio includes Eliquis (apixaban), Revlimid (lenalidomide), Pomalyst/Imnovid (pomalidomide), Sprycel (dasatinib), and Abraxane (paclitaxel albumin-bound particles for injectable suspension). Opdivo (nivolumab) is a fully human monoclonal antibody that binds to the PD-1 on T and NKT cells.

Webull offers Bristol-Myers Squibb Co stock information, including NYSE: BMY real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BMY stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BMY stock methods without spending real money on the virtual paper trading platform.